Less Ads, More Data, More Tools Register for FREE

Pin to quick picks96ES.L Regulatory News (96ES)

  • There is currently no data for 96ES

Director effectiveness assessment

13 Feb 2020 07:00

RNS Number : 8370C
Barclays PLC
13 February 2020
 

 

13 February 2020

Barclays PLCBarclays Bank PLC

Director effectiveness assessment: disclosure of regulatory investigation

In accordance with the UK Corporate Governance Code, all of the current Directors of Barclays PLC will be submitting themselves for election or re-election at the Annual General Meeting to be held on 7 May 2020, and will be unanimously recommended by the Board for election or re-election as appropriate. Further information in this regard will be set out in the Notice of Meeting which will be published in due course.

In deciding whether to recommend Jes Staley for re-election, the Board has carried out its usual formal and rigorous performance assessment, which it does in respect of the effectiveness of each of the Directors. As part of its determination in respect of Mr. Staley, the Board has had regard to media reports in the past 6 months that have highlighted historical links between Mr. Staley and Jeffrey Epstein.

As has been widely reported, earlier in his career Mr. Staley developed a professional relationship with Mr. Epstein. In the summer of 2019, in light of the renewed media interest in the relationship, Mr. Staley volunteered and gave to certain executives, and the Chairman, an explanation of his relationship with Mr. Epstein. Mr. Staley also confirmed to the Board that he has had no contact whatsoever with Mr. Epstein at any time since taking up his role as Barclays Group CEO in December 2015.

The relationship between Mr. Staley and Mr. Epstein was the subject of an enquiry from the Financial Conduct Authority ("FCA"), to which the Company responded. The FCA and the Prudential Regulation Authority subsequently commenced an investigation, which is ongoing, into Mr. Staley's characterisation to the Company of his relationship with Mr. Epstein and the subsequent description of that relationship in the Company's response to the FCA.

Based on a review, conducted with the support of external counsel, of the information available to us and representations made by Mr. Staley, the Board (the Executive Directors having been recused) believes that Mr. Staley has been sufficiently transparent with the Company as regards the nature and extent of his relationship with Mr. Epstein. Accordingly, Mr. Staley retains the full confidence of the Board, and is being unanimously recommended for re-election at the Annual General Meeting.

The Board will continue to cooperate fully with the regulatory investigation, and will provide a further update as and when it is appropriate to do so.

- ENDS -

For further information, please contact:

Investor Relations

Media Relations

Adam Strachan

Tom Hoskin

+1 212 526 8442

+44 (0) 20 7116 4755

James Johnson 

+44 (0)20 7116 7233

 

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customer and client, and geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services across the Group.

For further information about Barclays, please visit our website home.barclays 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLLLFBLLBBBB
Date   Source Headline
3rd May 20186:34 pmRNSPublication of Supplement 4/2017 to the GSSP BPs
3rd May 20185:09 pmRNSDelisting Notice
3rd May 20184:15 pmRNSPublication of a Prospectus
2nd May 20181:30 pmRNSPublication of Suppl.Prospcts
30th Apr 20181:45 pmRNSNotice to Bondholders of 9.5% bonds
23rd Apr 20188:36 amRNSPost Stabilisation Notice - OCBC
23rd Apr 20188:29 amRNSCMCIC - Pre-Stabilisation Notice
20th Apr 20187:00 amRNSFCA and PRA conclude investigations
19th Apr 20187:00 amRNSNotice to Bondholders of 9.5% Subordinated Bonds
18th Apr 20187:48 amRNSPublication of Final Terms
16th Apr 20188:41 amRNSPublication of Final Terms
11th Apr 201812:31 pmRNSPre-Stabilisation Notice OCBC
9th Apr 201811:09 amRNSPublication of Final Terms
3rd Apr 20184:30 pmRNSBarclays completes Ring-Fencing Transfer Scheme
29th Mar 20182:27 pmRNSSettlement of civil compliant with US DoJ re RMBS
29th Mar 201811:30 amRNSCovered Bond programme - Issuer substitution
28th Mar 201811:30 amRNSPublication of Final Terms
28th Mar 201810:58 amRNSPublication of Final Terms
23rd Mar 20183:58 pmRNSNotice of Substitution of Issuer
19th Mar 201810:20 amRNSDirectorate Change
19th Mar 20188:31 amRNSPublication of Final Terms
19th Mar 20188:25 amRNSPublication of Final Terms
19th Mar 20188:08 amRNSPublication of Final Terms
16th Mar 201812:15 pmRNSBarclays Bank PLC Registration document
16th Mar 201810:40 amRNSMSM - Cancellation Notice
15th Mar 201810:08 amRNSPublication of Final Terms
15th Mar 20188:00 amRNSPublication of Final Terms
14th Mar 20188:44 amRNSPublication of Final Terms
14th Mar 20188:42 amRNSPublication of Final Terms
9th Mar 20184:21 pmRNSBarclays RFTS Court Approval
9th Mar 20181:12 pmRNSRedemption Notice 7.75% Contingent Capital Notes
9th Mar 20181:05 pmRNSRedemption Notice 7.70% Subordinated Notes
23rd Feb 201811:15 amRNSAnnual Financial Report on Form 20-F
23rd Feb 20188:39 amRNSPublication of Final Terms
23rd Feb 20188:36 amRNSPublication of Final Terms
22nd Feb 20182:00 pmRNSBarclays Bank PLC Group ring-fencing update
22nd Feb 20182:00 pmRNSAnnual Financial Report & Final Results
20th Feb 20185:36 pmRNSChange of Maturity Date Class JV,JY& JI
20th Feb 20187:41 amRNSPublication of Final Terms
12th Feb 20182:47 pmRNSPublication of Final Terms
12th Feb 20187:00 amRNSSFO also charges Barclays Bank PLC
2nd Feb 20182:45 pmRNSPublication of Final Terms
2nd Feb 20182:08 pmRNSPublication of Final Terms
1st Feb 20189:20 amRNSPublication of Final Terms
24th Jan 20184:00 pmRNSPublication of Final Terms
15th Jan 20185:00 pmRNSPublication of Drawdown Prospectus
15th Jan 201812:26 pmRNSPublication of Final Terms
12th Jan 20187:36 amRNSPublication of Final Terms
10th Jan 20187:00 amRNSPublication of Final Terms
29th Dec 20178:40 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.